Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STOCKMEIER Group is a privately held, family-owned German chemicals group focused on the production and distribution of industrial and specialty chemical products and related services. The company operates across chemicals, food ingredients, tissue and textile, and polyurethane systems rather than as a drug-development or healthcare company. It manufactures and sells a broad portfolio of more than 26,000 products to customers worldwide and operates through a network of more than 60 locations. The group includes multiple operating subsidiaries involved in chemical distribution, production, and application-specific materials. For a biotech analyst, the key point is that STOCKMEIER Group is an industrial chemicals business, not a life sciences therapeutics or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STOCKMEIER Group.